Nanalyze
Quality: In-depth research on disruptive technology stocks
Clarity: Future-proof language everyone can easily understand
Objectivity: Taking the emotion out of investing with a straightforward approach
Humor: Giving you your daily recommended dose of sarcasm in every article
Newest Articles
Exact Sciences: The Best Stock for Cancer Blood Testing?
The world is divided in many ways these days, but we generally can all agree on at least one thing. Cancer sucks. Nearly 10 million people will die from some form of the disease this year, and there is about a 10% chance that you will meet your end thanks to the big C, according […]
The world is divided in many ways these days, but we generally can all agree...
About Nanalyze
We’re a team of MBAs with decades of experience who decided to work 80 hours a week for ourselves rather than 40 hours a week for someone else. Part researchers, part investment managers, part journalists, we deliver a straightforward, rules-based approach to investing that benefits new and seasoned investors alike. We specialize in two main investing strategies: disruptive technology (Nanalyze) and dividend growth (Quantigence). With real-money portfolios under management, we understand the importance of a risk-averse approach to investing. Through real-world examples, we teach people how to become better investors.
We are experts in the below fields
Sign up to our newsletter to get more of our great research delivered straight to your inbox!
Nanalyze Weekly includes useful insights written by our team of underpaid MBAs, research on new disruptive technology stocks flying under the radar, and summaries of our recent research. Always 100% free.
